These settlements are evidence of systemic, industry-wide problems that need to be addressed.

In recent years, the FDA has demonstrated a too-cozy relationship with the pharmaceutical industry and an attitude of shielding rather than disclosing information... The opportunity to name a new commissioner is a chance to take the agency in a necessary new direction.

Imports create competition and keep domestic industry more responsive to consumers. In the United States, we import everything consumers want. So why not pharmaceuticals?

I've always considered making it legal for Americans to import their prescription drugs a free-trade issue. Imports create competition and keep domestic industry more responsive to consumers.

The MPC still has to see conclusive sustained evidence that 2006 pay settlements are remaining contained.

I have very good evidence not that the process is broken but within the process there was just mischief,